Vernakalant vs propafenone vs flecainide in atrial fibrillation.
Phase of Trial: Phase III
Latest Information Update: 07 May 2014
Price : $35 *
At a glance
- Drugs Vernakalant (Primary) ; Flecainide; Propafenone
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 01 Oct 2013 New trial record
- 23 Sep 2013 Positive results published in the Journal of Atrial Fibrillation, according to a Cardiome media release. Top-line results also reported in the media release.